Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-29

Clinical Trial Update: A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients [Phase 4]

View source ↗

Summary

A Phase 4 study comparing Tacrolimus regimens Prograf plus Mycophenolate mofetil versus Advagraf plus Mycophenolate mofetil in liver transplant patients has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advagraf (tacrolimus)
  • MYFORTIC (MYCOPHENOLIC ACID)
  • Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED